BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wan X, Zhang D, Khan MA, Zheng S, Hu X, Zhang Q, Yang R, Xiong K. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement. Front Endocrinol 2022;13:859638. [DOI: 10.3389/fendo.2022.859638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Chen Z, Jin L, Zhao L, Meng L, Kong F, He C, Kong F, Zheng L, Liang F. LPS-pretreatment adipose-derived mesenchymal stromal cells promote wound healing in diabetic rats by improving angiogenesis. Injury 2022. [DOI: 10.1016/j.injury.2022.09.041] [Reference Citation Analysis]
2 Ghorbani-Dalini S, Azarpira N, Hossein Sangtarash M, Urbach V, Yaghobi R, Reza Soleimanpour-Lichaei H, Sarshar M. Optimization of 3D islet-like cluster derived from human pluripotent stem cells: an efficient in vitro differentiation protocol. Gene 2022;:146855. [PMID: 36058497 DOI: 10.1016/j.gene.2022.146855] [Reference Citation Analysis]
3 Park YM, Yang CM, Cho HY. Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model. IJMS 2022;23:6877. [DOI: 10.3390/ijms23136877] [Reference Citation Analysis]
4 Bhartiya D, Mohammad SA, Singh P, Sharma D, Kaushik A. GFP Tagged VSELs Help Delineate Novel Stem Cells Biology in Multiple Adult Tissues. Stem Cell Rev Rep 2022. [PMID: 35641711 DOI: 10.1007/s12015-022-10401-4] [Reference Citation Analysis]